FORWARD PHARMA A/S's ticker is FWP and the CUSIP is 34986J105. A total of 19 filers reported holding FORWARD PHARMA A/S in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,236,000 | -49.0% | 1,266,231 | -11.7% | 0.05% | -42.0% |
| Q4 2017 | $4,381,000 | -40.7% | 1,433,516 | -2.9% | 0.09% | -41.7% |
| Q3 2017 | $7,383,000 | -72.6% | 1,475,612 | -2.3% | 0.15% | -72.9% |
| Q2 2017 | $26,982,000 | -4.5% | 1,511,043 | +15.3% | 0.56% | -2.6% |
| Q1 2017 | $28,253,000 | +40.9% | 1,311,043 | -1.8% | 0.57% | +52.9% |
| Q4 2016 | $20,049,000 | -29.0% | 1,335,719 | -0.7% | 0.37% | -42.1% |
| Q3 2016 | $28,234,000 | +15.6% | 1,344,495 | 0.0% | 0.65% | +14.3% |
| Q2 2016 | $24,429,000 | +6.9% | 1,344,495 | 0.0% | 0.56% | +12.3% |
| Q1 2016 | $22,856,000 | +9.1% | 1,344,495 | +21.9% | 0.50% | +37.4% |
| Q4 2015 | $20,956,000 | -19.4% | 1,102,924 | 0.0% | 0.37% | -22.9% |
| Q3 2015 | $25,985,000 | +5.9% | 1,102,924 | +71.0% | 0.48% | +15.3% |
| Q2 2015 | $24,539,000 | +261.6% | 644,924 | +169.1% | 0.41% | +271.2% |
| Q1 2015 | $6,787,000 | – | 239,637 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 100,000 | $2,356,000 | 16.27% |
| BVF INC/IL | 1,016,324 | $23,945,000 | 4.84% |
| Baupost Group | 5,367,300 | $126,454,000 | 2.11% |
| Cormorant Asset Management, LP | 335,068 | $7,894,000 | 1.26% |
| EcoR1 Capital, LLC | 101,995 | $2,403,000 | 1.09% |
| HELLMAN JORDAN MANAGEMENT CO INC /MA/ | 157,397 | $3,708,000 | 0.92% |
| Assured Investment Management LLC | 1,102,924 | $25,985,000 | 0.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 135,000 | $3,181,000 | 0.41% |
| CLOUGH CAPITAL PARTNERS L P | 260,300 | $6,133,000 | 0.26% |
| Orbimed Advisors | 960,600 | $22,632,000 | 0.23% |